Translational Research Institute Australia

TRI has hosted a delegation from the Pacific Pension & Investment Institute (PPI) as part of a showcase of Boggo Road Innovation Precinct and Cross River Rail. The visit encompassed a showcase of the TRI building, our facilities and industry residents, as well as an explanation of our collaborative role within the precinct. We also detailed ENTRI, our cGMP manufacturing facility under construction and due to open in early 2026, with support from the Queensland Government and TRI. Erin Clark Chris Brown Russell Vine QIC Cross River Rail Delivery Authority

TRI will be well represented when the work of the Movement Disorder Society of Australia and New Zealand Clinical Trial Network is showcased in a public webinar tomorrow. Among the presenters are TRI-based Associate Professor Richard Gordon from QUT (Queensland University of Technology) (pictured left) and Associate Professor Alex Lehn from QUT and Queensland Health Metro South Health. The webinar will cover current and upcoming clinical trials, as well as the latest research developments in the field of movement disorders. There will also be a question and answer session. Read more: https://lnkd.in/gceBJMQx Parkinson's Australia Niamh Hennessy Aishwarya Johnson Joan Torony

A new framework has been launched, putting consumers and communities at the heart of health research. Health Translation Queensland has released the framework for consumer and community involvement in health research, helping researchers embed meaningful consumer and community involvement across every stage of the research cycle. HTQ Executive Director Dr Celia Webby says the framework represents "a major step forward in supporting researchers to design and deliver research that truly reflects the needs, values and priorities of the people it aims to benefit". Explore the framework: https://lnkd.in/djJwqY_A TRI has contributed to the framework development, alongside Queensland Health, Children's Health Queensland Hospital and Health Service, Metro North Health, Metro South Health, Gold Coast Hospital and Health Service, West Moreton Hospital and Health Service, Mater, The University of Queensland and QUT (Queensland University of Technology), Griffith University, QIMR Berghofer, CSIRO's AEHRC, Health Consumers Queensland, Sunshine Coast Health Institute and the University of Southern Queensland.

Welcome to Queensland's burgeoning life sciences hub, delegates from the Singapore Economic Development Board (EDB). Delegates visited TRI and adjoining Thermo Fisher Scientific to gain a better understanding of Brisbane's Knowledge Corridor, incorporating Boggo Road Innovation Precinct. They toured the facilities and heard how precinct partners are collaborating, creating critical mass and developing a translational pipeline in clinical sciences, cGMP manufacturing, biotechnology, immunology, and vaccine and therapeutic development. A key facility is ENTRI, our cGMP manufacturing facility under construction and due to open in early 2026, with support from the Queensland Government and TRI. Sam Hyde Glenda Colburn Clare Blain Erin Clark Pengfei (PF) Chen Yan Qi C. Mark Jacobs Andrew Tran (陳煌豪) Syed Mudassir Department of the Environment, Tourism, Science and Innovation Brisbane Economic Development Agency QIC Trade and Investment Queensland Kym Baker Trent Munro

TRI Industry Development and Tenancy Manager Glenda Colburn will be in Melbourne this week for the AusBiotech International Conference. TRI will be exhibiting at the Queensland State Pavilion and sharing details of our pre-clinical, clinical, or cGMP biomedical manufacturing facilities. Our facilities include ENTRI, a purpose-designed cGMP manufacturing facility under construction and due to open in early 2026, with support from the Queensland Government and TRI. AusBiotech International Conference 2025 connects Australian expertise with domestic and international partnerships for knowledge sharing, forging collaborations and exploring opportunities to go global. Read more about ENTRI: https://lnkd.in/gdERiN6M Read more about AusBiotech 2025: https://ausbiotechic.com/ Shari Armistead GAICD FIML, Maher Gandhi

Should grant reviewers – who are often our colleagues – judge the legitimacy of career breaks due to personal circumstances? It’s a question Associate Professor Nathalie Bock, the QUT (Queensland University of Technology) Research Lead at TRI, poses in a career column in Nature. Associate Professor Bock explores ideas including independent panels with medical, psychological and disability-equity specialists to review applications from researchers with career disruptions. The column also details family experiences in 2021 that caused career disruptions for both Associate Professor Bock and her partner – and led to the sharing of personal information with peers. It’s something she hopes others can avoid in the future. “My hope is that career breaks … no longer blunt a person’s competitiveness or push talented researchers out of academia.” Read more: https://lnkd.in/gpusthz5  Read the column in Nature: https://lnkd.in/gXCbjJJU Springer Nature Max Planck Queensland Centre (MPQC)

Congratulations, TRI General Counsel and Company Secretary Kirsten Kiel-Chisholm, a finalist in the Governance Top 100. The top 100 highlights the talent and achievements of people who take their role in governance to the next level. The winner will be announced on Friday 24 October. Read more: https://lnkd.in/gqrTJQdB

TRI CEO Professor Maher Gandhi is starting next week's AusBiotech International Conference 2025 with a presentation at a Life Sciences Queensland Ltd (LSQ) breakfast.   Professor Gandhi’s speech topic is TRI: Innovative Australian Example of a Translational Ecosystem in Action.   Prof. Chris Molloy, the founding CEO of the Medicines Discovery Catapult in the UK, will be speaking after Professor Gandhi.   AusBiotech International Conference 2025 connects Australian expertise with domestic and international partnerships for knowledge sharing, forging collaborations and exploring opportunities to go global.   Read more and register for the breakfast: https://lnkd.in/gp3hhVkn Read more about AusBiotech 2025: https://ausbiotechic.com/   Rebekah Cassidy Sue Coke Denise Johnston Lisa Cavallaro Trent Munro Natalie Davis Glenda Colburn Shari Armistead GAICD FIML

A collaboration between TRI-based researchers from The University of Queensland and Yale University is using a ‘Google maps’ approach to revolutionise lung cancer treatment. Associate Professor Arutha Kulasinghe from UQ Frazer Institute (pictured right) is part of the team, along with Dr James Monkman and Rafael Tubelleza. They studied tumours from 234 people with non-small cell lung cancer in Australia, the United States and Europe, with results published in Nature Genetics. AI and spatial biology were used to map cells to understand and predict treatment response; and pinpoint areas within a tumour that are either responsive or therapy-resistant. “Rather than having to use a trial-and-error approach, oncologists will now know which treatments are most likely to work with new precision medicine tools,” A/Prof Kulasinghe says. Read more: https://lnkd.in/ggnpJvHu Read the publication: https://lnkd.in/edG_Kera Springer Nature WEHI (Walter and Eliza Hall Institute of Medical Research) Cure Cancer PA Research Foundation Wesley Research Institute National Institutes of Health Chin Wee Tan Kenneth O'Byrne

“We are very collaborative. We position ourselves as partners with the researchers.” Dr Brian Tse heads TRI's Preclinical Imaging Facility, one of the best equipped facilities of its kind in Australia to support research discovery, help in designing experiments and contribute to publications. Researchers using the Preclinical Imaging Facility can leverage multiple imaging modalities in a single longitudinal study. Dr Tse's team provides training on image acquisition and data analysis, as well as expert advice on project development, research grants and ethics applications. Read more: https://lnkd.in/gK8RG4fN